An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience. Gynecol Oncol. 2017 11; 147(2):243-249.

View in: PubMed

subject areas

Adenocarcinoma, Clear Cell
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Cystadenocarcinoma, Serous
Disease-Free Survival
Female
Humans
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Paclitaxel
Prognosis
Proportional Hazards Models
Randomized Controlled Trials as Topic
Survival Rate

authors with profiles

Gini Fleming